NASDAQ
Goldenwell Biotech, Inc. (GWLL) has a free cash flow growth of -152.01% as of Friday, May 29, 2026. This represents a 312.84% decrease compared to its 12-month average of 71.42%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.